If you used AMBOSS at medical school, you remember the experience — the searchable library that made pathophysiology accessible, the integrated Q-bank with "smart" highlighting, and the satisfying depth of the clinical content. The question for GP trainees is whether that medical school resource remains useful for postgraduate MRCGP preparation — or whether it is a comfort blanket from a previous phase of training.
What AMBOSS Offers
AMBOSS provides a searchable medical knowledge library with integrated Q-bank. The library covers pathophysiology, pharmacology, and clinical management across all medical specialties. The "smart" tooling includes keyword highlighting, cross-references between articles and questions, and study plan features.
The content is strong for hospital-based medicine — cardiology, respiratory, gastroenterology, endocrinology, neurology. The pathophysiology explanations are among the best available in any medical resource. For understanding why a condition presents the way it does, why a drug works the way it does, or why a complication occurs, AMBOSS is excellent. The Q-bank integrates with the knowledge library — when you answer a question, you can click through to the relevant article for deep-dive learning. The study plan features help structure revision over a defined period. AMBOSS is used heavily during medical school and early postgraduate training globally.
Where AMBOSS Falls Short for MRCGP
The MRCGP AKT tests three domains: clinical medicine (80%), evidence-based practice (10%), and organisational/administrative topics (10%). AMBOSS covers the clinical domain well — but with a global rather than UK-specific perspective. NICE/CKS management pathways, UK prescribing conventions, and NHS-specific organisational topics are not AMBOSS's strength.
The AKT organisational domain (QOF, NHS contracts, clinical governance, screening programmes, medico-legal frameworks) is not covered by AMBOSS at all. The evidence-based practice domain (NNT/NNH, sensitivity/specificity, study design interpretation, meta-analysis) is partially covered but not mapped to the RCGP curriculum.
The SCA is not addressed — AMBOSS has no SCA-specific content, no consultation simulation, and no RCGP-domain marking.
Who Should Use AMBOSS for MRCGP
AMBOSS is useful as a pathophysiology refresher — if you encounter a condition in clinic that you have not thought about since medical school (pheochromocytoma, Wilson's disease, sarcoidosis), AMBOSS provides the deepest, most accessible explanation available. For this specific use case — refreshing core medical knowledge for conditions you rarely see in primary care — it is excellent. The depth of explanation, the visual diagrams, and the pathophysiology walkthroughs make complex conditions understandable in a way that concise CKS pages or Q-bank explanations cannot match.
It is not a primary AKT revision tool. For AKT-specific preparation, you need a UK-mapped Q-bank (Passmedicine, Pastest, or iatroX) that covers all three AKT domains including organisational and EBP content.
Where iatroX Fits
AMBOSS covers broad medical knowledge with global context. iatroX is built specifically for UK clinical practice — with NICE/CKS/BNF RAG integration that AMBOSS does not offer. Use AMBOSS for pathophysiology refreshers when you need deep understanding. Use iatroX for UK-specific AKT drilling, guideline-grounded clinical Q&A, and adaptive revision mapped to the RCGP blueprint.
The Bottom Line
AMBOSS is a world-class medical knowledge platform — but it is designed for a global audience and is strongest in hospital-based medicine. For MRCGP AKT preparation, it is a supplementary tool for pathophysiology refreshers, not a primary revision resource. The 20% of the AKT that tests organisational and evidence-based practice content is simply not covered. If you still have an AMBOSS subscription from medical school, use it for deep-dive refreshers on conditions you encounter in clinic. For dedicated, focused AKT-specific preparation, invest in a UK-mapped Q-bank — and iatroX provides one for free.